Published in Stroke on September 01, 1994
1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. CMAJ (1998) 4.95
Posterior leukoencephalopathy syndrome. Postgrad Med J (2001) 3.07
Is Canada falling behind international standards for stroke care? CMAJ (1998) 2.09
The Ischemic Stroke Genetics Study (ISGS) Protocol. BMC Neurol (2003) 1.98
Neurological emergencies: acute stroke. J Neurol Neurosurg Psychiatry (2000) 1.62
Consensus in stroke management? BMJ (1999) 0.97
Clinical review: Therapy for refractory intracranial hypertension in ischaemic stroke. Crit Care (2007) 0.94
Current Epidemiology and Outcome of Infective Endocarditis: A Multicenter, Prospective, Cohort Study. Medicine (Baltimore) (2015) 0.91
Use of antithrombotic medications among elderly ischemic stroke patients. Circ Cardiovasc Qual Outcomes (2010) 0.83
Bio-Repository of DNA in stroke (BRAINS): a study protocol. BMC Med Genet (2011) 0.83
Aetiopathogenesis and long-term outcome of isolated pontine infarcts. J Neurol (2005) 0.81
Early transoesophageal echocardiography in cryptogenic and lacunar stroke and transient ischaemic attack. J Neurol Neurosurg Psychiatry (1998) 0.81
Recent advances in the acute management of ischaemic stroke. J Accid Emerg Med (1999) 0.80
Acute supratentorial ischemic stroke: when surgery is mandatory. Biomed Res Int (2014) 0.75
Arterial indications for the low molecular weight heparins. Curr Control Trials Cardiovasc Med (2001) 0.75
Management of acute ischemic stroke. An update for primary care physicians. West J Med (1997) 0.75
Use of anticoagulants in patients with acute ischemic stroke. Stroke (1995) 0.75
Effectiveness of regionalized systems for stroke and myocardial infarction. Brain Behav (2015) 0.75
Guidelines on stroke management. Ital J Neurol Sci (1998) 0.75
Complementary examinations other than neuroimaging and neurosonology in acute stroke. World J Clin Cases (2017) 0.75
Measurements of acute cerebral infarction: a clinical examination scale. Stroke (1989) 14.54
Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA (2000) 7.25
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med (2001) 7.07
Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke (1993) 6.94
Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med (1988) 6.78
A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. N Engl J Med (1992) 5.93
The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg (1990) 4.72
Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology (1999) 4.49
Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke (1994) 4.45
Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology (2000) 4.13
A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med (1989) 3.83
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology (1998) 3.62
Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology (2007) 3.56
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol (1992) 3.49
Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA (2000) 3.43
Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2004) 3.34
Verifying the stroke-free phenotype by structured telephone interview. Stroke (2000) 3.15
Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med (1989) 2.97
Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke (1999) 2.85
Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke (1994) 2.85
Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation (1994) 2.84
Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med (1999) 2.82
Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv (2000) 2.77
Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery (1994) 2.74
Design of the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST). Int J Stroke (2010) 2.71
Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis (1997) 2.67
The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results. J Neurosurg (1990) 2.64
White matter hyperintensity volume is increased in small vessel stroke subtypes. Neurology (2010) 2.49
Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol (1991) 2.34
Neurologic manifestations of atrial myxoma. A 12-year experience and review. Stroke (1988) 2.30
Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. Stroke (1998) 2.25
Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology (1983) 2.24
Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA (2001) 2.24
Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg (1981) 2.23
Is there a Persian Gulf War syndrome? Evidence from a large population-based survey of veterans and nondeployed controls. Am J Med (2000) 2.23
Circadian variation in onset of acute ischemic stroke. Arch Neurol (1990) 2.22
Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke (1999) 2.17
A modified National Institutes of Health Stroke Scale for use in stroke clinical trials: preliminary reliability and validity. Stroke (2001) 2.16
Early treatment for acute ischemic stroke. Ann Intern Med (1989) 2.15
Residential radon gas exposure and lung cancer: the Iowa Radon Lung Cancer Study. Am J Epidemiol (2000) 2.13
Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science (1985) 2.10
The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology (1995) 2.10
Prospective reliability of the STRokE DOC wireless/site independent telemedicine system. Neurology (2005) 2.08
Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment. Neurology (2003) 2.04
Ischemic cerebrovascular complications and risk factors in idiopathic hypertrophic subaortic stenosis. Stroke (1991) 2.03
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology (2002) 2.02
Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum Mol Genet (1999) 1.98
Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke (2001) 1.97
Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology (1999) 1.93
Diagnosis and management of neurological sarcoidosis. Arch Intern Med (1997) 1.93
The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology (1993) 1.91
The declining incidence of stroke. N Engl J Med (1979) 1.86
CT and clinical correlations in recent aneurysmal subarachnoid hemorrhage: a preliminary report of the Cooperative Aneurysm Study. Neurology (1983) 1.86
Guidelines for carotid endarterectomy: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke (1998) 1.85
Animal models of stroke: are they relevant to human disease? Stroke (1990) 1.82
Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? NINDS t-PA Stroke Study Group. Stroke (1999) 1.82
Frequency, risk factors, anatomy, and course of unilateral neglect in an acute stroke cohort. Neurology (2004) 1.81
Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter. Stroke (1996) 1.79
Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation. Breast Cancer Res Treat (2011) 1.77
Measurements of acute cerebral infarction: lesion size by computed tomography. Stroke (1989) 1.74
Prestroke physical activity and early functional status after stroke. J Neurol Neurosurg Psychiatry (2009) 1.73
Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Stroke (2000) 1.71
Anterior choroidal artery territory infarction: a small vessel disease. Stroke (1989) 1.69
Brain tissue sodium is a ticking clock telling time after arterial occlusion in rat focal cerebral ischemia. Stroke (2000) 1.68
Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation (1998) 1.65
Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke (1998) 1.64
Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke (1992) 1.64
Prognostic and clinical relevance of pupillary responses, intracranial pressure monitoring, and brainstem auditory evoked potentials in comatose patients with acute supratentorial mass lesions. Crit Care Med (1993) 1.63
Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST Investigators. Neurology (1993) 1.63